Nutrien Ltd. NTR reported worse-than-expected Q1 financial results and issued FY23 adjusted EPS guidance below estimates.
Nutrien posted adjusted earnings of $1.11 per share, missing analysts’ estimates of $1.49 per share. The company’s quarterly sales came in at $6.11 billion, missing expectations of $6.43 billion.
Nutrien said it sees FY23 adjusted earnings of $5.50 to $7.50 per share, versus analysts’ estimates of $8.63 per share.
Nutrien shares fell 4.1% to trade at $59.19 on Friday.
These analysts made changes to their price targets on Nutrien following earnings announcement.
- Barclays cut the price target on Nutrien from $93 to $80. Barclays analyst Benjamin Theurer maintained an Overweight rating.
- Mizuho lowered the price target on Nutrien from $79 to $75. Mizuho analyst Christopher Parkinson maintained a Neutral rating
- RBC Capital cut Nutrien price target from $100 to $95. RBC Capital analyst Andrew Quail maintained the stock with an Outperform.
- Credit Suisse, on Thursday, slashed Nutrien price target from $70 to $60. Credit Suisse analyst Edlain Rodriguez reiterated the stock with an Underperform.
Check This Out: Top 5 Industrials Stocks That May Explode In Q2
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.